Association of GSTM1, GSTT1, GSTM3, and GSTP1 Genes Polymorphisms with Susceptibility to Osteosarcoma: a Case- Control Study and Meta-Analysis

Document Type : Systematic Review and Meta-analysis

Authors

1 Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

2 Department of Orthopedics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

3 Department of Anesthesiology and Critical Care, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

4 Department of Basic Science, Faculty of Veterinary Medicine, Ardakan University, Ardakan, Iran.

5 Department of Radiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

6 Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Abstract

Background: Some studies have investigated the association of GSTM1, GSTT1, GSTM3, and GSTP1
polymorphisms with susceptibility to osteosarcoma; however, these studies results are inconsistent and inconclusive. In
order to drive a more precise estimation, the present case-control study and meta-analysis was performed to investigate
association of GSTM1, GSTT1, GSTM3, and GSTP1 polymorphisms with osteosarcoma. Methods: Eligible articles
were identified by a search of several electronic databases for the period up to May 5, 2018. Odds ratios were pooled
using either fixed-effects or random effects models. Results: Finally, a total of 24 case-control studies with 2,405
osteosarcoma cases and 3,293 controls were included in the present meta-analysis. Overall, significantly increased
osteosarcoma risk was found when all studies were pooled into the meta-analysis of GSTT1 (Null vs. Present: OR= 1.247
95% CI 1.020-1.524, P= 0.031) and GSTP1 polymorphism (B vs. A: OR= 8.899 95% CI 2.722-29.094, P≤0.001). In
the stratified, significantly increased osteosarcoma risk was observed for GSTT1 polymorphism among Asians (Null
vs. Present: OR= 1.300 95% CI 1.034-1.635, P= 0.025), but not among Caucasians. Conclusions: This meta-analysis
demonstrated that GSTP1 and GSTT1 null genotype are associated with the risk of osteosarcoma. Future large welldesigned epidemiological studies are warranted to validate our results.

Keywords

Main Subjects


Volume 20, Issue 3
March 2019
Pages 675-682
  • Receive Date: 03 May 2018
  • Revise Date: 06 December 2018
  • Accept Date: 08 January 2019
  • First Publish Date: 01 March 2019